2022
Keys to Achieving Clinically Important Weight Loss: Perceptions of Responders and Nonresponders in the Clinic and Community Approaches to Healthy Weight Trial
Fay C, Castro I, Velez D, Ruggiero C, O'Connor G, Perkins M, Luo M, Sharifi M, Mini F, Taveras E, Kuhlthau K, Fiechtner L. Keys to Achieving Clinically Important Weight Loss: Perceptions of Responders and Nonresponders in the Clinic and Community Approaches to Healthy Weight Trial. Childhood Obesity 2022, 19: 507-514. PMID: 36315223, PMCID: PMC10698771, DOI: 10.1089/chi.2022.0112.Peer-Reviewed Original ResearchConceptsPediatric weight management interventionsBody mass index improvementWeight management interventionsImportant weight lossUnmet social needsPerspectives of caregiversHealthy weightHealth behaviorsNonrespondersSemistructured guideThematic saturationWeight lossWeight stigmaRespondersMindful eating
2021
Characteristics of achieving clinically important weight loss in two paediatric weight management interventions
Fiechtner L, Castro I, Cheng ER, Sharifi M, Gerber MW, Luo M, Goldmann D, Sandel M, Block J, Orav EJ, Taveras EM. Characteristics of achieving clinically important weight loss in two paediatric weight management interventions. Pediatric Obesity 2021, 16: e12784. PMID: 33734583, PMCID: PMC8355061, DOI: 10.1111/ijpo.12784.Peer-Reviewed Original ResearchConceptsPediatric weight management interventionsWeight management interventionsSevere obesityImportant weight lossSugary beveragesWeight lossBMI z-scoreLog-binomial regressionYears of ageHealth trialsMultivariable analysisLower BMILifestyle behaviorsAssociation of childAnalysis of childrenYounger ageZ-scoreObesityManagement interventionsLower likelihoodInterventionChildrenAgeBeveragesYears
2012
The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity
Sarr MG, Billington CJ, Brancatisano R, Brancatisano A, Toouli J, Kow L, Nguyen NT, Blackstone R, Maher JW, Shikora S, Reeds DN, Eagon JC, Wolfe BM, O’Rourke R, Fujioka K, Takata M, Swain JM, Morton JM, Ikramuddin S, Schweitzer M, Chand B, Rosenthal R, The EMPOWER Study Group. The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity. Obesity Surgery 2012, 22: 1771-1782. PMID: 22956251, DOI: 10.1007/s11695-012-0751-8.Peer-Reviewed Original ResearchConceptsImportant weight lossControl groupWeight lossMorbid obesityVagal blockadePercent excess weight lossSubdiaphragmatic vagal nerveExcess weight lossSerious adverse eventsDuration of therapyDevice-related complicationsBody mass indexMain outcome measuresDevice useResultsStudy subjectsVagal transmissionAdverse eventsVagal nerveMulticenter trialMass indexFeasibility trialEMPOWER studyOutcome measuresInformed consentTherapy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply